Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 Nov 15;14(1):28109.
doi: 10.1038/s41598-024-79853-7.

Effects of exercise and dietary interventions on asprosin, leptin, and lipid metabolism in males with abdominal obesity, a randomized controlled trial

Affiliations
Randomized Controlled Trial

Effects of exercise and dietary interventions on asprosin, leptin, and lipid metabolism in males with abdominal obesity, a randomized controlled trial

Agnieszka Suder et al. Sci Rep. .

Abstract

Addressing abdominal obesity requires multifaceted strategies, with physical activity and diet playing a pivotal role. The objective of this study was to assess alterations in body composition, adipokine concentrations, insulin resistance parameters, and lipid metabolism in males with abdominal obesity following two distinct interventions: exercise alone and exercise combined with a specific diet. The study involved 44 males with abdominal obesity (average age 34.7 ± 5.5 years, waist circumference [WC] 110.3 ± 8.5), randomly assigned to three groups: an experimental group with aerobic-resistance exercise (EG, n = 16), an experimental group with aerobic-resistance exercise combined with a high-protein, low-glycemic index carbohydrate diet (EDG, n = 16), both interventions lasting 6 weeks, and a control group without interventions (CG, n = 12). Body composition (body mass [BM], body fat percentage [BF%], fat-free mass [FFM], android body fat percentage [ANDR]), as well as biochemical blood analyses (asprosin [ASP], leptin [LEP], quantitative insulin sensitivity check index [QUICKI], and total cholesterol [TC]), were conducted at baseline and after 6 weeks of intervention. The impact of interventions on the analyzed variables among groups was assessed using mixed ANOVA tests with post-hoc comparisons. Effect size (ES) was also evaluated using 𝜂p2. Significant reductions in ASP concentration after intervention were observed in both EG (p = 0.04) and EDG (p = 0.01). However, post-hoc tests revealed a decrease in LEP only in the EDG group (p < 0.01). In EDG substantial decreases after 6 weeks of intervention were noted in BM (p < 0.01), BF% (p < 0.01), ANDR (p < 0.01) and TC (p < 0.01). The most notable increase in FFM was observed in the EDG group (p < 0.01). More favourable metabolic outcomes were confirmed in the group combining diet with exercise, where there was a notable reduction in ASP levels by 16% and LEP by 48% after 6 weeks of intervention, compared to the group undergoing exercise alone.

PubMed Disclaimer

Conflict of interest statement

Declarations Competing interests The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Changes in asprosin (ASP) [ng/ml] concentration in the control (CG), exercise (EG) and exercise-diet (EDG) groups during weeks of examinations.
Fig. 2
Fig. 2
Changes in leptin (LEP) [ng/ml] concentration in the control (CG), exercise (EG) and exercise-diet (EDG) groups during weeks of examinations.
Fig. 3
Fig. 3
The flowchart of the study.

References

    1. Bray, G. A. & Bouchard, C. The biology of human overfeeding: a systematic review. Obes. Rev.21, 13040. 10.1111/obr.13040 (2020). - PubMed
    1. Hinney, A., Körner, A. & Fischer-Posovszky, P. The promise of new anti-obesity therapies arising from knowledge of genetic obesity traits. Nat. Rev. Endocrinol.18, 623–637. 10.1038/s41574-022-00716-0 (2022). - PMC - PubMed
    1. Choe, S. S., Huh, J. Y., Hwang, I. J., Kim, J. I. & Kim, J. B. Adipose tissue remodeling: its role in energy metabolism and metabolic disorders. Front. Endocrinol. (Lausanne). 7, 30. 10.3389/fendo.2016.00030 (2016). - PMC - PubMed
    1. Romere, C. et al. Asprosin, a fasting-induced glucogenic protein hormone. Cell. 165, 566–579. 10.1016/j.cell.2016.02.063 (2016). - PMC - PubMed
    1. Hoffmann, J. G., Xie, W. & Chopra, A. R. Energy regulation mechanism and therapeutic potential of asprosin. Diabetes. 69, 559–566. 10.2337/dbi19-0009 (2020). - PMC - PubMed

Publication types